Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats

Gisele F. Bomfim, Rosangela A. dos Santos, Maria Aparecida Oliveira, Fernanda R. Giachini, Eliana H. Akamine, Rita C. Tostes, Zuleica B. Fortes, R. Clinton Webb, Maria Helena C. Carvalho

Research output: Contribution to journalArticlepeer-review

151 Scopus citations


Activation of TLRs (Toll-like receptors) induces gene expression of proteins involved in the immune system response. TLR4 has been implicated in the development and progression of CVDs (cardiovascular diseases). Innate and adaptive immunity contribute to hypertension-associated end-organ damage, although the mechanism by which this occurs remains unclear. In the present study, we hypothesize that inhibition of TLR4 decreases BP (blood pressure) and improves vascular contractility in resistance arteries from SHR (spontaneously hypertensive rats). TLR4 protein expression in mesenteric resistance arteries was higher in 15-week-old SHR than in age-matched Wistar controls or in 5-week-old SHR. To decrease the activation of TLR4, 15-week-old SHR and Wistar rats were treated with anti-TLR4 (anti-TLR4 antibody) or non-specific IgG control antibody for 15 days (1 μg per day, intraperitoneal). Treatment with anti-TLR4 decreased MAP (mean arterial pressure) as well as TLR4 protein expression in mesenteric resistance arteries and IL-6 (interleukin 6) serum levels from SHR when compared with SHR treated with IgG. No changes in these parameters were found in treated Wistar control rats. Mesenteric resistance arteries from anti-TLR4-treated SHR exhibited decreased maximal contractile response to NA (noradrenaline) compared with IgG-treated SHR. Inhibition of COX (cyclo-oxygenase)-1 and COX-2, enzymes related to inflammatory pathways, decreased NA responses only in mesenteric resistance arteries of SHR treated with IgG. COX-2 expression and TXA 2 (thromboxane A 2) release were decreased in SHR treated with anti-TLR4 compared with IgG-treated SHR. Our results suggest that TLR4 activation contributes to increased BP, low-grade inflammation and plays a role in the augmented vascular contractility displayed by SHR.

Original languageEnglish (US)
Pages (from-to)535-543
Number of pages9
JournalClinical Science
Issue number11
StatePublished - Jun 2012
Externally publishedYes


  • Cyclo-oxygenase
  • Hypertension
  • Inflammation
  • Mesenteric resistance artery
  • Toll-like receptor 4 (TLR4)

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats'. Together they form a unique fingerprint.

Cite this